MeiraGTx Holdings (MGTX) Depreciation & Amortization (CF) (2017 - 2025)
MeiraGTx Holdings (MGTX) reported Depreciation & Amortization (CF) of $3.1 million for Q4 2025, up 1.43% on a YoY basis from $3.1 million in Q4 2024, and down 1.27% quarter-over-quarter from $3.2 million in Q3 2025.
MeiraGTx Holdings (MGTX) Depreciation & Amortization (CF) (2017 - 2025) Analysis & Trends
MeiraGTx Holdings has reported Depreciation & Amortization (CF) for 9 years, with the latest figure at $3.1 million in Q4 2025.
- For the quarter ending Q4 2025, Depreciation & Amortization (CF) rose 1.43% year-over-year to $3.1 million; the trailing twelve-month figure through Dec 2025 stood at $12.5 million (down 2.21% YoY), and the FY2025 full-year result was $12.5 million, down 2.23% from the prior year.
- Depreciation & Amortization (CF) for Q4 2025 stood at $3.1 million, down from $3.2 million in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $3.9 million in Q4 2023, with the low at $1.8 million in Q1 2021.
- Historically, Depreciation & Amortization (CF) has averaged $2.8 million across 5 years, with a median of $3.1 million in 2023.
- Annual changes were most pronounced in 2021 — Depreciation & Amortization (CF) surged 115.71% — and 2024, when it dropped 21.5%.
- MeiraGTx Holdings' Depreciation & Amortization (CF) stood at $2.1 million in 2021, then increased by 20.85% to $2.5 million in 2022, then jumped by 56.98% to $3.9 million in 2023, then dropped by 21.5% to $3.1 million in 2024, then rose by 1.43% to $3.1 million in 2025.
- The last three Depreciation & Amortization (CF) figures came in at $3.1 million (Q4 2025), $3.2 million (Q3 2025), and $3.2 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1,395.22 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 55.90 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 429,663.65 |
| 10 | MeiraGTx Holdings | 910.47 Mn | 844.54 Mn | 74.89 Mn | 3.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.12 Mn |
| Dec 31, 2025 | 3.12 Mn |
| Sep 30, 2025 | 3.16 Mn |
| Sep 30, 2025 | 3.16 Mn |
| Jun 30, 2025 | 3.19 Mn |
| Jun 30, 2025 | 3.19 Mn |
| Mar 31, 2025 | 3.08 Mn |
| Mar 31, 2025 | 3.08 Mn |
| Dec 31, 2024 | 3.07 Mn |
| Dec 31, 2024 | 3.07 Mn |
| Sep 30, 2024 | 3.26 Mn |
| Sep 30, 2024 | 3.26 Mn |
| Jun 30, 2024 | 3.22 Mn |
| Jun 30, 2024 | 3.22 Mn |
| Mar 31, 2024 | 3.28 Mn |
| Mar 31, 2024 | 3.28 Mn |
| Dec 31, 2023 | 3.91 Mn |
| Dec 31, 2023 | 3.91 Mn |
| Sep 30, 2023 | 3.48 Mn |
| Sep 30, 2023 | 3.48 Mn |